Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 4
1997 7
1998 2
1999 9
2000 1
2001 5
2002 2
2003 4
2004 4
2005 3
2006 2
2007 7
2008 9
2009 4
2010 3
2011 4
2012 6
2013 6
2015 4
2016 2
2017 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

81 results
Results by year
Filters applied: . Clear all
Page 1
[Radionuclide therapy].
Senekowitsch-Schmidtke R. Senekowitsch-Schmidtke R. Biomed Tech (Berl). 1997;42 Suppl:525-7. Biomed Tech (Berl). 1997. PMID: 9517267 German. No abstract available.
DCA promotes progression of neuroblastoma tumors in nude mice.
Feuerecker B, Seidl C, Pirsig S, Bruchelt G, Senekowitsch-Schmidtke R. Feuerecker B, et al. Among authors: senekowitsch schmidtke r. Am J Cancer Res. 2015 Jan 15;5(2):812-20. eCollection 2015. Am J Cancer Res. 2015. PMID: 25973318 Free PMC article.
The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer.
Willhauck MJ, Samani BR, Wolf I, Senekowitsch-Schmidtke R, Stark HJ, Meyer GJ, Knapp WH, Göke B, Morris JC, Spitzweg C. Willhauck MJ, et al. Among authors: senekowitsch schmidtke r. Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1272-81. doi: 10.1007/s00259-008-0775-4. Epub 2008 Apr 11. Eur J Nucl Med Mol Imaging. 2008. PMID: 18404268
Tracking of [18F]FDG-labeled natural killer cells to HER2/neu-positive tumors.
Meier R, Piert M, Piontek G, Rudelius M, Oostendorp RA, Senekowitsch-Schmidtke R, Henning TD, Wels WS, Uherek C, Rummeny EJ, Daldrup-Link HE. Meier R, et al. Among authors: senekowitsch schmidtke r. Nucl Med Biol. 2008 Jul;35(5):579-88. doi: 10.1016/j.nucmedbio.2008.02.006. Epub 2008 May 2. Nucl Med Biol. 2008. PMID: 18589302
81 results